Immunologic therapy for relapsing-remitting multiple sclerosis.
- 1 May 2001
- journal article
- research article
- Published by Springer Science and Business Media LLC in Current Neurology and Neuroscience Reports
- Vol. 1 (3), 277-285
- https://doi.org/10.1007/s11910-001-0031-9
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Clinical studies on multiple sclerosisActa Neurologica Scandinavica, 2009
- Etiology and Pathogenesis of Multiple SclerosisSeminars in Neurology, 1998
- Management of Multiple SclerosisNew England Journal of Medicine, 1997
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosisAnnals of Neurology, 1995
- High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Overview of azathioprine treatment in multiple sclerosisThe Lancet, 1991
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965